Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
08 nov. 2016 08h00 HE
|
Galectin Therapeutics
NORCROSS, Ga., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer,...